CCO
0.003
50%
CLU
0.008
-27.3%
RNX
0.003
50%
EM3
0.135
-20.6%
GLL
0.007
40%
TXR
0.004
-20%
NYR
0.575
38.6%
RB6
0.125
-19.4%
WRX
0.024
26.3%
EXR
0.1
-16.7%
CYC
0.61
25.8%
PAT
0.066
-16.5%
EXP
0.1
25%
ICL
0.021
-16%
EGA
0.16
23.1%
TRE
0.295
-15.7%
AX8
0.006
20%
AXL
0.075
-15.7%
IPD
0.006
20%
ADR
0.11
-15.4%
MEG
0.018
20%
CTO
0.011
-15.4%
RFT
0.006
20%
AHF
0.017
-15%
KEY
0.08
19.4%
AEV
0.006
-14.3%
LPM
0.125
19%
AXP
0.006
-14.3%
BMM
0.064
18.5%
CMO
0.006
-14.3%
SRJ
0.013
18.2%
EM2
0.006
-14.3%
NOR
0.02
17.6%
NWM
0.006
-14.3%
PSL
0.034
17.2%
OMG
0.006
-14.3%
H3E
0.007
16.7%
M3M
0.025
-13.8%
PET
0.007
16.7%
BAK
0.22
-13.7%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Vitrafy Life Sciences (ASX:VFY): Lists on ASX

Vitrafy Life Sciences has listed on the ASX with a ticker code of VFY. The company has designed and developed an innovative cryopreservation solution, which has application across many uses in animal and human health. Having proven its technology, Vitrafy is now pursuing additional product development initiatives and collaboration agreements.

Website: https://vitrafy.com/
Board: Sonia Petering – Chair, Assoc Professor John McBain – Chair, Scientific Advisory Board and Non-Executive Director, Brent Owens – Deputy Chief Executive Officer, Co-Founder and Executive Director, Kate Munnings – Chief Executive Officer, Vaughan Webber – Non‑Executive Director
Management: Kate Munnings – Chief Executive Officer, Simon Martin – Chief Financial Officer
Media: The Stock Network Lel Smits